Serum uric acid levels and its association with cardiovascular risk factors

Iranian Journal of Public Health

Volumn 38, Issue 1, 2009, Pages 53-59

  Sadr, S M ^a   Namayandeh, S M ^a   Moadares, M M ^a   Rafiei, M ^a  

^a Yazd Medical University   (Iran)

Author keywords

Cardiovascular; Hyperuricemia; Ischemic heart disease; Metabolic syndrome; Risk Factor

Indexed keywords

EID: 67649419340     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Robert I (2001). Disorders of purine and primidine metabolism. In: Horrison's Principles of internal medicine. Eds, Kasper and Braunwald. 15st. Mc Graw-hill, New York, pp. 2268-71.
2. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, et al. (1996). Relationship of uric acid concentration to cardiovascular risk factors in young men. The role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord, 20: 975-80.
3. Rathmann W, Funkhouser E, Dyer AR, Roseman JM (1998). Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Annals Epidemiol, (4): 250-61.
4. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M (2004). Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 4-9.
5. Nebulas I, Yuko I, Toda EI, Nagai R, Yamakado M, (2005). Association between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals. Arterioscler Thromb Vasc Biol, 25: 1038-44.
6. Culleton BF, Larson MG, Kannel WB, Levy D (1999). Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med, 131: 7-13.
7. Lehto S, Niskanen L, Ronnemaa T, Laakso M (1998). Serum uric acid is a strong predictor of stroke in patients with noninsulin-dependent diabetes mellitus. Stroke, 29: 635-39.
8. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini, M, Trevisan M (1994). Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens, 8: 677-81.
9. Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S (2004). Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res, 27:227-33.
10. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sarý I, et al (2006). Serum Uric Acid Is a Determinant of Metabolic Syndrome in a Population-Based Study. AJH, 19:1055-62.
11. Facchini F, Ida Chen Y-D, Hollenbeck CB, Reaven GM (1991). Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA, 266: 3008-11.
12. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, et al. (1998). Influence of long-term low-dose diuretic-based antihypertensive therapy on glucose lipid uric acid and potassium levels in older men and women with isolated systolic hypertension. Arch Int Med, 158: 741-51.
13. Bengtsson C (1979). Elevated serum uric acid levels during treatment with antihypertensive drugs. Acta Med Scand Supple, 628: 69-71.
14. Messerli FH, Froehlich ED, Dreslinski GR, Suarez DH, Aristimuno GG (1980). Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med, 93: 817-21.
15. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH (1966). Hyperuricemia in primary and renal hypertension. N Engl J Med, 275: 457-64.
16. Reaven GM (1997). The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis, 30(6): 928-31.
17. Quinones GA, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E (1995). Effect of insulin on uric acid excretion in humans. Am J Physiol, 268:1-5.
18. Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, Sironi AM, et al. (1996). Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens, 9:746-52.
19. Reaven GM, Lithell H, Landsberg L (1996). Hypertension and associated metabolic abnormalities the role of insulin resistance and the sympathoadrenal system. N Engl J Med, 334: 374-81.
20. Fessel WJ (1980). High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med, 68:401-4.
21. Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J (1988). Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand, 224:549 -55.
22. Freedman DS, Williamson DF, Gunter EW, Byers T (1995). Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol, 141:637-44.
23. Brand FN, McGee DL, Kannel WB, Stokes J III, Castelli WP (1985). Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol, 121: 11-18.
24. Wheeler JG, Kelsey M, Juzwishin M, Eiriksdottir G, Gudnason V, Danesh J (2006). Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis. PLoS Med, 2(3): 0236-024., freely available: http://www.plosmedicine.org
25. Iribarren C, Sharp DS, Curb JD, Yano K (1996). High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers. J Clin Epidemiol, 49:673-78.
26. Chapelle JP, Albert A, Boland J, Smeets JP, Heusghem C, Kulbertus HE (1982). Critical evaluation of serum uric acid levels in acute myocardial infarction. Clin Chim Acta, 121:147-57.
27. Tuttle KR, Short RA, Johnson RJ (2001). Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol, 87: 1411-14.
28. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ et al. (2004). Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired santioxidative activity. J Clin Endocrinol Metab, 89: 4963-71.
29. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG (2000). Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 148: 31-39.
30. Culleton BF, Larson MG, Kannel WB, Levy D (1999). Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med, 131: 7-13.
31. Mikkelsen WM, Dodge HJ, Valkenburg H (1965). The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. Am J Med, 39: 242-51.
32. Gordon T, Kannel WB (1983). Drinking and its relation to smoking, blood pressure, blood lipids, and uric acid. The Framingham Study. Arch Int Med, 143: 1366-74.